BCL2 and bronchopulmonary dysplasia: Identifying pro-apoptotic proteins that BCL2 counteracts, such as BAX, BAK, and/or BOK, and unraveling their upstream regulators will provide further insights into AMF apoptosis mechanisms, which may be disrupted during impaired alveologenesis in bronchopulmonary dysplasia.